GSK-1070916 (GMP)

Overview

GSK-1070916 (GMP) is GSK-1070916 ( HY-70044 ) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. GSK-1070916 is a potent and selective ATP-competitive inhibitor of aurora B and aurora C with K i s of 0.38 and 1.5 nM, respectively, and is >250- fold selective over Aurora A .

Application

Products | Products > GMP Small Molecules | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Aurora Kinase

Product Information

• Catalog No.: HY-70044G
• CAS No.: 942918-07-2
• Molecular Formula: C30H33N7O
• Molecular Weight: 507.63
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source